Why Are People Talking About Investing in WPC?

More and more people are talking about W. P. Carey over the last few weeks. Is it worth buying the Specialty Real Estate Investment Trust stock at a price of $62.24? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • W. P. Carey has moved -22.0% over the last year, and the S&P 500 logged a change of 13.0%

  • WPC has an average analyst rating of hold and is 4.71% away from its mean target price of $59.44 per share

  • Its trailing earnings per share (EPS) is $3.64

  • W. P. Carey has a trailing 12 month Price to Earnings (P/E) ratio of 17.1 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $2.01 and its forward P/E ratio is 31.0

  • The company has a Price to Book (P/B) ratio of 1.46 in contrast to the S&P 500's average ratio of 2.95

  • W. P. Carey is part of the Real Estate sector, which has an average P/E ratio of 24.81 and an average P/B of 2.24

  • WPC has reported YOY quarterly earnings growth of 13.7% and gross profit margins of 0.9%

  • The company has a free cash flow of $634.99 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Celebrating its 50th anniversary, W. P. Carey ranks among the largest net lease REITs with a well-diversified portfolio of high-quality, operationally critical commercial real estate, which includes 1,413 net lease properties covering approximately 171 million square feet and a portfolio of 86 self-storage operating properties, pro forma for the Spin-Off of NLOP, as of September 30, 2023. With offices in New York, London, Amsterdam and Dallas, the company remains focused on investing primarily in single-tenant, industrial, warehouse and retail properties located in the U.S. and Northern and Western Europe, under long-term net leases with built-in rent escalations.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.